Skip to main content
Erschienen in: Familial Cancer 4/2014

01.12.2014 | Original Article

Association of interleukin-23 receptor gene polymorphisms with risk of bladder cancer in Chinese

verfasst von: Tielong Tang, Hui Xue, Shu Cui, Zhiyong Gong, Zhonghai Fei, Shulin Cheng, Chunyan Gui

Erschienen in: Familial Cancer | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

To assess whether polymorphisms of the interleukin-23 receptor (IL23R) gene are associated with bladder transitional cell carcinoma because chronic inflammation contributes to bladder cancer and the IL23R is known to be critically involved in the carcinogenesis of various malignant tumors. 226 patients with bladder cancer and 270 age-matched controls were involved in the study. Polymerase chain reaction–restriction fragment length polymorphism was used for genotyping. Genotype distribution and allelic frequencies between patients and controls were compared. In all three single nucleotide polymorphisms of IL23R studied, the distribution of genotype and allele frequencies of rs10889677 differed significantly between patients and controls. The frequency of allele C of rs10889677 was significantly increased in cases compared with controls (0.2898 vs. 0.1833, odds ratio 1.818, 95 % confidence interval 1.349–2.449). The result indicates that IL23R may play an important role in the susceptibility of bladder cancer in Chinese population.
Literatur
2.
Zurück zum Zitat Cresswell J, Robertson H, Neal DE, Griffiths TR, Kirby JA (2001) Distribution of lymphocytes of the alpha(E)beta(7) phenotype and E-cadherin in normal human urothelium and bladder carcinomas. Clin Exp Immunol 126(3):397–402PubMedCentralPubMedCrossRef Cresswell J, Robertson H, Neal DE, Griffiths TR, Kirby JA (2001) Distribution of lymphocytes of the alpha(E)beta(7) phenotype and E-cadherin in normal human urothelium and bladder carcinomas. Clin Exp Immunol 126(3):397–402PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Parham C, Chirica M, Timans J et al (2002) A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 168(11):5699–5708PubMedCrossRef Parham C, Chirica M, Timans J et al (2002) A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 168(11):5699–5708PubMedCrossRef
5.
Zurück zum Zitat Kim TH, Hong JM, Oh B et al (2008) Association of polymorphisms in the Interleukin 23 receptor gene with osteonecrosis of femoral head in Korean population. Exp Mol Med 40(4):418–426PubMedCentralPubMedCrossRef Kim TH, Hong JM, Oh B et al (2008) Association of polymorphisms in the Interleukin 23 receptor gene with osteonecrosis of femoral head in Korean population. Exp Mol Med 40(4):418–426PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Huber AK, Jacobson EM, Jazdzewski K, Concepcion ES, Tomer Y (2008) Interleukin (IL)-23 receptor is a major susceptibility gene for Graves’ ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. J Clin Endocrinol Metab 93(3):1077–1081. doi:10.1210/jc.2007-2190 PubMedCentralPubMedCrossRef Huber AK, Jacobson EM, Jazdzewski K, Concepcion ES, Tomer Y (2008) Interleukin (IL)-23 receptor is a major susceptibility gene for Graves’ ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. J Clin Endocrinol Metab 93(3):1077–1081. doi:10.​1210/​jc.​2007-2190 PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Chen J, Lu Y, Zhang H et al (2010) A nonsynonymous polymorphism in IL23R gene is associated with risk of gastric cancer in a Chinese population. Mol Carcinog 49(10):862–868. doi:10.1002/mc.20661 PubMedCrossRef Chen J, Lu Y, Zhang H et al (2010) A nonsynonymous polymorphism in IL23R gene is associated with risk of gastric cancer in a Chinese population. Mol Carcinog 49(10):862–868. doi:10.​1002/​mc.​20661 PubMedCrossRef
14.
Zurück zum Zitat Newton RC, Beral V, Weiss R, Imperial Cancer Research Fund (Great Britain) (1999) Infections and human cancer. Cold Spring Harbor Laboratory Press, Plainview Newton RC, Beral V, Weiss R, Imperial Cancer Research Fund (Great Britain) (1999) Infections and human cancer. Cold Spring Harbor Laboratory Press, Plainview
16.
Zurück zum Zitat Macarthur M, Hold GL, El-Omar EM (2004) Inflammation and cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 286(4):G515–G520. doi:10.1152/ajpgi.00475.2003 PubMedCrossRef Macarthur M, Hold GL, El-Omar EM (2004) Inflammation and cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 286(4):G515–G520. doi:10.​1152/​ajpgi.​00475.​2003 PubMedCrossRef
19.
21.
Zurück zum Zitat Pirhonen J, Matikainen S, Julkunen I (2002) Regulation of virus-induced IL-12 and IL-23 expression in human macrophages. J Immunol 169(10):5673–5678PubMedCrossRef Pirhonen J, Matikainen S, Julkunen I (2002) Regulation of virus-induced IL-12 and IL-23 expression in human macrophages. J Immunol 169(10):5673–5678PubMedCrossRef
27.
Zurück zum Zitat Du JW, Xu KY, Fang LY, Qi XL (2012) Interleukin-17, produced by lymphocytes, promotes tumor growth and angiogenesis in a mouse model of breast cancer. Mol Med Rep 6(5):1099–1102. doi:10.3892/mmr.2012.1036 PubMed Du JW, Xu KY, Fang LY, Qi XL (2012) Interleukin-17, produced by lymphocytes, promotes tumor growth and angiogenesis in a mouse model of breast cancer. Mol Med Rep 6(5):1099–1102. doi:10.​3892/​mmr.​2012.​1036 PubMed
Metadaten
Titel
Association of interleukin-23 receptor gene polymorphisms with risk of bladder cancer in Chinese
verfasst von
Tielong Tang
Hui Xue
Shu Cui
Zhiyong Gong
Zhonghai Fei
Shulin Cheng
Chunyan Gui
Publikationsdatum
01.12.2014
Verlag
Springer Netherlands
Erschienen in
Familial Cancer / Ausgabe 4/2014
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-014-9731-6

Weitere Artikel der Ausgabe 4/2014

Familial Cancer 4/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.